Chris Boshoff: The importance of the patient experience in everything we do
Chris Boshoff shared on Linkedin:
” This week at Pfizer was Patients In Focus, a global, week-long activation to emphasize the importance of the patient experience in everything we do.
Through hundreds of colleague events, from speaker panels with patients and advocates to a Volunteer Event with Baglt Cancer Support, we are building bridges with the community and keeping patients at the center of our work as we strive to overcome cancer’s greatest challenges.
While we prioritize patients every day, Patients in Focus week reminds us that patients are at the center of everything we do.
Through ongoing collaboration, we aim to accelerate innovation and help improve the lives of people with cancer around the globe.”
Source: Chris Boshoff/Linkedin
Chris Boshoff is a leading American medical oncologist renowned for his expertise in oncology research and development. As the Chief Oncology Officer and Executive Vice President at Pfizer, he plays a pivotal role in steering the company’s efforts in advancing cancer treatment and precision medicine.
His role as the founding Director of the University College London Cancer Institute highlights his deep expertise and dedication to the field. With over 150 highly cited publications, Boshoff’s research has made significant contributions to the understanding of cancer biology, tumor virology, and experimental cancer medicine.
Under his leadership, Pfizer has achieved numerous global approvals for innovative cancer medicines and developed various companion diagnostics, further advancing precision medicine. Chris Boshoff’s extensive experience and leadership continue to drive progress in oncology research and treatment.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023